Maintaining complete, compliant documentation during a trial can be challenging. ISFs help ensure ICH E6 (R2) section 8 are met by checking the content of a variety of documents.
Fireside Chats, a new virtual series presented by Advarra, launches this month, bringing the research community together to discuss challenges and potential solutions.
In a recent webinar, Advarra IRB and research compliance experts discussed key areas to consider when ramping up research in the COVID-19 pandemic’s “new normal.”
Q&A: Gene Therapy Research in the Age of COVID-19: Study Startup for Infectious Disease, Oncology, and Rare Disease Research
In Advarra’s inaugural virtual symposium, experts from industry and academia met to discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants.
On June 3, members of the research community gathered virtually to discuss updates on hot topics and emerging issues in gene therapy.
Biosafety has surged to the spotlight due to the current COVID-19 global pandemic, motivating sites to conduct a risk assessment and develop a risk mitigation plan.
Advarra’s Virtual Symposium will highlight progress made with gene therapy, as well as begin conversations about obstacles to overcome.
Everyone wants to be part of a strong work culture, but how does your organization get there? Check out three tips for building a stronger work culture.